Howard Hughes Medical Institute’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Howard Hughes Medical Institute’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,416	Closed	-$142K	–	136
2017 Q2	$142K	Sell	1,416 -88	-6%	-$9.47K	0.03%	131
2017 Q1	$182K	Sell	1,504 -164	-10%	-$20.1K	0.03%	118
2016 Q4	$186K	Buy	1,668 +421	+34%	+$50.7K	0.04%	121
2016 Q3	$166K	Buy	+1,247	New	+$119K	0.04%	129

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Howard Hughes Medical Institute's GWPH Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2017, closing a stake of 1,416 shares — an estimated $142K sold.

Howard Hughes Medical Institute first reported a position in GWPH in Q3 2016 and held it in 4 quarters. The position peaked at $186K in Q4 2016. 181 funds tracked by Wall St. Rank hold GWPH as of Q3 2017.

Howard Hughes Medical Institute reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2017 after selling out during the quarter.
Howard Hughes Medical Institute sold 1,416 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2017, an estimated $142K.
Howard Hughes Medical Institute first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 4 quarters.
Howard Hughes Medical Institute's GW Pharmaceuticals Plc American Depositary Shares position peaked at $186K in Q4 2016.
181 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.